These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3546461)

  • 1. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab.
    Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ
    J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection.
    De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A
    J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin Fab.
    Johnson LL; Lerrick KS; Coromilas J; Seldin DW; Esser PD; Zimmerman JM; Keller AM; Alderson PO; Bigger JT; Cannon PJ
    Circulation; 1987 Jul; 76(1):181-90. PubMed ID: 2439232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.
    Frist W; Yasuda T; Segall G; Khaw BA; Strauss HW; Gold H; Stinson E; Oyer P; Baldwin J; Billingham M
    Circulation; 1987 Nov; 76(5 Pt 2):V81-5. PubMed ID: 3311460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Fab antimyosin in cardiac imaging.
    Johnson LL
    Clin Cardiol; 1992 Mar; 15(3):145-53. PubMed ID: 1551261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection.
    Breuer M; Schütz A; Engelhardt M; Hammer C; Kemkes BM
    Angiology; 1999 Jul; 50(7):563-71. PubMed ID: 10431996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.
    Puig M; Ballester M; Matías-Guiu X; Bordes R; Carrió I; Kolodgie FD; Pons C; García A; Aymat MR; Marrugat J; Brossa V; Campreciós M; Padró JM; Caralps JM; Virmani R; Prat J; Narula J
    J Nucl Cardiol; 2000; 7(2):132-9. PubMed ID: 10796002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
    Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
    J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimyosin imaging in cardiac transplant rejection.
    Johnson LL; Cannon PJ
    Circulation; 1991 Sep; 84(3 Suppl):I273-9. PubMed ID: 1884496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents.
    Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA
    J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts.
    Isobe M; Haber E; Khaw BA
    Circulation; 1991 Sep; 84(3):1246-55. PubMed ID: 1884451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine on the uptake of monoclonal antibody to cardiac myosin.
    Allen MD; Shoji Y; Fujimura Y; Eary JF; Reichenbach DD; Thomas R; Gordon D
    J Heart Lung Transplant; 1991; 10(5 Pt 1):775-81. PubMed ID: 1958686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection.
    Schuetz A; Fritsch S; Kemkes BM; Kugler C; Angermann C; Spes C; Anthuber M; Weiler A; Wenke K; Gokel JM
    J Heart Transplant; 1990; 9(6):654-61. PubMed ID: 2277304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin.
    Nishimura T; Sada M; Sasaki H; Yutani C; Hayashi M; Amemiya H; Fujita T; Akutsu T; Manabe H
    Eur J Nucl Med; 1987; 13(7):343-7. PubMed ID: 3322830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of severity of cardiac rejection in heterotopic heart transplantation using indium-111 antimyosin and magnetic resonance imaging.
    Nishimura T; Sada M; Sasaki H; Yutani C; Fujita T; Amemiya H; Kozuka T; Akutsu T; Manabe H
    Cardiovasc Res; 1988 Feb; 22(2):108-12. PubMed ID: 3048691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with the application of monoclonal Indium-111 antimyosin scintigraphy in the diagnosis of rejection episodes following orthotopic heart transplantation].
    Hartmann A; Baum RP; Klepzig H; Huth A; Mondorf U; Herrmann G; Cieslinski G; Olbrich HG; Hör G; Krause E
    Z Kardiol; 1991 Jul; 80(7):454-8. PubMed ID: 1926991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications.
    Ballester M; Obrador D; Carrió I; Augé JM; Moya C; Pons-Lladó G; Caralps-Riera JM
    Circulation; 1990 Dec; 82(6):2100-7. PubMed ID: 2242534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and dynamics of acute rejection after heterotopic heart transplantation.
    Schüetz A; Kemkes BM; Breuer M; Brandl U; Engelhardt M; Kugler C; Manz C; Hatz R; Gokel JM; Hammer C
    J Heart Lung Transplant; 1992; 11(2 Pt 1):289-99; discussion 299-300. PubMed ID: 1576135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?
    Ueda K; Takeda K; LaFrance ND; Solez K; Baumgartner WA; Reitz BA; Herskowitz A
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):778-81. PubMed ID: 2831646
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of cardiac allograft rejection and myocyte necrosis by monoclonal antibody to cardiac myosin.
    Allen MD; Tsuboi H; Togo T; Eary JF; Gordon D; Thomas R; Reichenbach DD
    Transplantation; 1989 Dec; 48(6):923-8. PubMed ID: 2595780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.